Xin-Yu Liang, Li-Yuan Mu, Lei Hu, Rui-Ling She, Chen-Yu Ma, Jun-Han Feng, Zhi-Yu Jiang, Zhao-Xing Li, Xiu-Quan Qu, Bai-Qing Peng, Kai-Nan Wu, Ling-Quan Kong
PURPOSE: Glycated hemoglobin (HbA1c) is widely used in diabetes management and now recommended for diagnosis and risk assessment. Our research focused on investigating the optimal cutoff points of HbA1c for diagnosis of diabetes and prediabetes in Chinese breast cancer women, aiming to enhance early detection and tailor treatment strategies. PATIENTS AND METHODS: This study involved 309 breast cancer women without diabetes history in China. Patients were categorized into groups of newly diagnosed diabetes, prediabetes, and normal glucose tolerance using oral glucose tolerance test (OGTT) according to the 2010 ADA criteria...
2024: International Journal of General Medicine